Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Changes in the Incidence and Overall Survival of Patients with Myeloproliferative Neoplasms between 2002 and 2016 in the United States

Srdan Verstovsek, MD PhD, Jingbo Yu, MD PhD, Robyn M. Scherber, MD, Shivani Pandya, MS, Christopher Dieyi, MPH, Chien-Cheng Chen, MS, Shreekant Parasuraman, BPharm, PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141090

Published: 2020

Journal Articles

Thrombotic Events and Mortality Risk in Patients Newly Diagnosed with Intermediate- to High-Risk Essential Thrombocythemia in the United States

Naveen Pemmaraju, MD, Aaron T. Gerds, MDMS, Jingbo Yu, MD PhD, Shreekant Parasuraman, BPharm, PhD, Anne Shah, Ann Xi, PharmD, Shambhavi Kumar, MS, Robyn M. Scherber, MD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141333

Published: 2020

Journal Articles

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

Blood (2020) 136 (Supplement 1): 1–3.

https://doi.org/10.1182/blood-2020-138953

Published: 2020

Journal Articles

Thrombosis and Risk of Mortality in Newly Diagnosed High-Risk Polycythemia Vera: An Analysis of the Medicare Claims Database in the United States

Naveen Pemmaraju, MD, Aaron T. Gerds, MDMS, Shreekant Parasuraman, BPharm, PhD, Jingbo Yu, MD PhD, Anne Shah, Ann Xi, PharmD, Shambhavi Kumar, MS, Robyn M. Scherber, MD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-141370

Published: 2020

Journal Articles

Clinical Characteristics and Treatment Patterns By Risk Stratification in Patients with Essential Thrombocythemia: An Analysis of the MOST Study

Michael R. Grunwald, MD, Ivy Altomare, MD, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-134841

Published: 2020

Journal Articles

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Rami S. Komrokji, MD, Brady L. Stein, MD MHSc, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 49–51.

https://doi.org/10.1182/blood-2020-134958

Published: 2020

Journal Articles

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

Brady L. Stein, MD MHSc, Kamal Patel, MD, Robyn M. Scherber, MD, Jingbo Yu, MD PhD, Dilan Paranagama, PhD, Carole B. Miller, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-137144

Published: 2020

Journal Articles

Prevalence and Risk Factors for Opioid-Related Complications in Patients with Myeloproliferative Neoplasms: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Holly L. Geyer, MD, Robyn M. Scherber, MD MPH, Gina Mazza, PhD, Blake Langlais, Leslie Padrnos, MD, Jeanne Palmer, MD, Amylou C. Dueck, PhD, Ruben A. Mesa, MD

Blood (2018) 132 (Supplement 1): 4297.

https://doi.org/10.1182/blood-2018-99-115143

Published: 2018

Journal Articles

Addressing the Adequacy of Current MPN Pain Management Strategies: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Holly L. Geyer, MD, Robyn M. Scherber, MD MPH, Gina Mazza, PhD, Blake T. Langlais, Ruben A. Mesa, MD, Leslie Padrnos, MD, Amylou C. Dueck, PhD, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2018-99-115095

Published: 2018

Journal Articles

Utilization of Patient-Reported Outcomes in Myeloproliferative Neoplasm Clinical Trials Registered at Clinicaltrials.Gov

Blake T. Langlais, Gina Mazza, PhD, Crystal S. Langlais, MPH, Heidi E. Kosiorek, MS, Holly L. Geyer, MD, Ruben A. Mesa, MD, Robyn M. Scherber, MD MPH, Amylou C. Dueck, PhD

Blood (2018) 132 (Supplement 1): 5469.

https://doi.org/10.1182/blood-2018-99-117446

Published: 2018

Journal Articles

Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis

Jeanne Palmer, MD, Heidi E. Kosiorek, MS, Christine Wolschke, MD, Veena D. S. Fauble, MD, Richard Butterfield, III, Holly Geyer, MD, Robyn M. Scherber, MD, Amylou C. Dueck, PhD, Allison Gathany, MD, Ruben A. Mesa, MD FACP, Nicolaus Kroeger, MD

Blood (2018) 132 (Supplement 1): 4827.

https://doi.org/10.1182/blood-2018-99-111420

Published: 2018

Journal Articles

Tobacco Use in the Myeloproliferative Neoplasms: Patient Behavior, Opinions, and Care

Robyn M. Scherber, MD MPH, Holly L. Geyer, MD, Gina Mazza, PhD, Blake T. Langlais, Amylou C. Dueck, PhD, Jeanne Palmer, MD, Leslie Padrnos, MD, Angela Fleischman, MD PhD, Ruben A. Mesa, MD

Blood (2018) 132 (Supplement 1): 5846.

https://doi.org/10.1182/blood-2018-99-117559

Published: 2018

Journal Articles

Quality of Life and Symptom Burden Among Patients with Myeloproliferative Neoplasms: Do Symptoms Impact Quality of Life?

Blake T. Langlais, Heidi Kosiorek, MS, Holly Geyer, MD, Robyn M. Scherber, MD, Ruben A Mesa, MD, Amylou C. Dueck, PhD

Blood (2017) 130 (Supplement 1): 3453.

https://doi.org/10.1182/blood.V130.Suppl_1.3453.3453

Published: 2017

Journal Articles

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Robyn M. Scherber, MD, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Holly Geyer, MD, Zhenya Senyak, Archie McCallister, MD, Mary Cotter, MA, Barbara VanHusen, Jeanne Palmer, MD, Leslie Padrnos, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 5657.

https://doi.org/10.1182/blood.V130.Suppl_1.5657.5657

Published: 2017

Journal Articles

Needs and Preferences Regarding Nutrition and Supplement Use Among Individuals with Myeloproliferative Neoplasms: A Focus Group Study

Robyn M. Scherber, MD, Sarah Morse, MS, Anais Leproux, PhD, Brianna M Craver, MS, Hew Yeng Lai, Holly Geyer, MD, Amylou C. Dueck, PhD, Jeanne Palmer, MD, Leslie Padrnos, MD, Ruben A Mesa, MD, Angela G. Fleischman, MD PhD

Blood (2017) 130 (Supplement 1): 5669.

https://doi.org/10.1182/blood.V130.Suppl_1.5669.5669

Published: 2017

Journal Articles

Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial

Allison Scotch, MD MPH, Robyn M. Scherber, MD, Marlene Bruso, MS, Heidi Elizabeth Kosiorek, MS, Amylou C. Dueck, PhD, Holly Geyer, MD, Veena D. S. Fauble, MD, Alessandro M. Vannucchi, Ana Kerguelen Fuentes, Christen Lykkegaard Andersen, PhD, Elisabeth Ejerblad, MD, Gunnar Birgegard, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, David M Ross, MBBS, PhD FRACP, FRCPA, Federico Sackman, MD PhD, Jean-Loup Demory, MD PhD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Jan J. Michiels, PhD, Deepti Radia, MD, Joanne Ewing, PhD BMBS, BSc, FRPATH,, Frances Wadelin, MD, Robert N. Lown, MBBS, MRCP, MD, Mary Frances McMullin, MB,Bch BAO, MD FRCPath, Wunna Swe, Jonathan O. Cullis, MD, Nigel Sargant, BSc, FRPATH, MRCP,, Paul Moreton, MD MRCP, FRCPath, Catherine Cargo, MB, FRCPath, Mallika Sekhar, MBBS, MD FRCPath, FRCP, Satareh Shekouhi, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 1641.

https://doi.org/10.1182/blood.V130.Suppl_1.1641.1641

Published: 2017

Journal Articles

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Leslie Padrnos, MD, Robyn M. Scherber, MD, Blake T. Langlais, Amylou Dueck, PhD, Jennifer Huberty, PhD, Holly L. Geyer, MD, Krisstina L. Gowin, DO, Heidi Kosiorek, MS, Marlene Bruso, MS, Zhenya Senyak, MA, Matthew M Clark, PhD, Michael Boxer, MD, Mary Cotter, MA, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2161.

https://doi.org/10.1182/blood.V130.Suppl_1.2161.2161

Published: 2017

Journal Articles

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Leslie Padrnos, MD, Heidi Kosiorek, MS, Robert M Bennett, III, Amylou Constance Dueck, PhD, Krisstina L. Gowin, DO, Robyn M. Scherber, MD, Holly L. Geyer, MD, Jeanne Palmer, MD, Donald Northfelt, MD, Joseph R Mikhael, MD FRCPC, MD, Nandita Khera, MD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2162.

https://doi.org/10.1182/blood.V130.Suppl_1.2162.2162

Published: 2017

Journal Articles

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Robyn M. Scherber, MD, Blake T. Langlais, Holly Geyer, MD, Amylou Dueck, PhD, Heidi Kosoriek, MS, Carol Johnston, PhD RD, Leslie Padrnos, MD, Jeanne Palmer, MD, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2193.

https://doi.org/10.1182/blood.V130.Suppl_1.2193.2193

Published: 2017

Journal Articles

Sleep and Psychiatric Disturbance in Chronic Philadelphia Negative Myeloproliferative Neoplasms

Krisstina L. Gowin, DO, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Denise Millstine, MD, Jennifer Huberty, PhD, Ryan Eckert, MS, Leslie Padrnos, MD, Robyn M. Scherber, MD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 4189.

https://doi.org/10.1182/blood.V130.Suppl_1.4189.4189

Published: 2017

NARROW

Changes in the Incidence and Overall Survival of Patients with Myeloproliferative Neoplasms between 2002 and 2016 in the United States

Thrombotic Events and Mortality Risk in Patients Newly Diagnosed with Intermediate- to High-Risk Essential Thrombocythemia in the United States

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

Thrombosis and Risk of Mortality in Newly Diagnosed High-Risk Polycythemia Vera: An Analysis of the Medicare Claims Database in the United States

Clinical Characteristics and Treatment Patterns By Risk Stratification in Patients with Essential Thrombocythemia: An Analysis of the MOST Study

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

Prevalence and Risk Factors for Opioid-Related Complications in Patients with Myeloproliferative Neoplasms: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Addressing the Adequacy of Current MPN Pain Management Strategies: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Utilization of Patient-Reported Outcomes in Myeloproliferative Neoplasm Clinical Trials Registered at Clinicaltrials.Gov

Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis

Tobacco Use in the Myeloproliferative Neoplasms: Patient Behavior, Opinions, and Care

Quality of Life and Symptom Burden Among Patients with Myeloproliferative Neoplasms: Do Symptoms Impact Quality of Life?

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Needs and Preferences Regarding Nutrition and Supplement Use Among Individuals with Myeloproliferative Neoplasms: A Focus Group Study

Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Sleep and Psychiatric Disturbance in Chronic Philadelphia Negative Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only